Drug Profile
Research programme: 5T4 tumour antigen imaging - ImaginAb/Oxford BioMedica
Alternative Names: 5T4-targeted PET tracer - ImaginAb/Oxford BioMedicaLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator ImaginAb
- Developer ImaginAb Inc
- Class Antibodies; Antibody diagnostics; Imaging agents
- Mechanism of Action Positron-emission tomography enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Ovarian cancer